Vannucci Fernando, Araújo José Augusto
Thoracic Surgery Department, Hospital Federal do Andaraí, Rio de Janeiro, Brazil.
Thoracic Surgery Department, Hospital Central da Polícia Militar (HCPM), Rio de Janeiro, Brazil.
J Thorac Dis. 2017 Apr;9(Suppl 3):S178-S192. doi: 10.21037/jtd.2017.04.04.
Sympathectomy and its variations have been performed in thoracic surgery for more than 100 years. However, its indications have undergone profound modifications in this period. Likewise, since then the surgical technique has also evolved dramatically up to the minimally invasive techniques worldwide accessible in present days. Currently, primary hyperhidrosis is, by far, the main indication for thoracic sympathectomy and this procedure is usually carried out thoracoscopically with excellent results. However, until today, hyperhidrosis is a part of thoracic surgery still surrounded by controversy, persisting as an open field over which some confusion still resides regarding its pathophysiology, terms definitions and operative approaches. The aim of this article is to provide a wide but easily comprehensible review of the theme, discussing and clarifying the major concepts with respect to its clinical presentation, all the presently available treatment options and strategies with their potential benefits and risks, the adequate patient selection for sympathectomy, as well as the postoperative clinical results.
交感神经切除术及其变体在胸外科手术中应用已有100多年历史。然而,在此期间其适应证发生了深刻变化。同样,自那时以来,手术技术也有了巨大发展,直至如今全球范围内可采用的微创技术。目前,原发性多汗症是胸交感神经切除术的主要适应证,该手术通常通过胸腔镜进行,效果良好。然而,直到今天,多汗症仍是胸外科手术中仍存在争议的一部分,在其病理生理学、术语定义和手术方法方面仍存在一些混淆,仍是一个有待开拓的领域。本文旨在对该主题进行广泛但易于理解的综述,讨论并阐明关于其临床表现、目前所有可用治疗选择和策略及其潜在益处和风险、交感神经切除术合适的患者选择以及术后临床结果的主要概念。